Grant T. Baldwin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Grant T. Baldwin has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Alana Marie Vivolo-Kantor
Division of Overdose Prevention, National Center for Injury Prevention and Control, CDC, Atlanta, Georgia, USA
1 shared publication - Amy S. B. Bohnert
Department of Psychiatry, University of Michigan Medical School, Ann Arbor, MI, USA
1 shared publication B. Casey Lyons
Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA
1 shared publication- Brooke E. Hoots
Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
1 shared publication - Bruce A. Goldberger
Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine , Gainesville, FL 32607
1 shared publication - David A. Sleet
Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
1 shared publication
Latest Publications
- Open Access
- 29 September 2026
- Published by Elsevier in American Journal of Preventive Medicine
Availability of Toxicology Testing Results Among Drug Overdose Deaths, U.S., 2020–2024
- 29 September 2026
- Published by Elsevier in American Journal of Preventive Medicine
Open AccessAvailability of Toxicology Testing Results Among Drug Overdose Deaths, U.S., 2020–2024
- 22 September 2026
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 32 (6S) , S155-S157
Built to Adapt—Cross-Sector Coalitions Still Driving Youth Substance Use Prevention Through the Drug-Free Communities Program
Was not provided for this article.
- 22 September 2026
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 32 (6S) , S155-S157
Built to Adapt—Cross-Sector Coalitions Still Driving Youth Substance Use Prevention Through the Drug-Free Communities Program
Was not provided for this article.
- 11 March 2026
- Published by Elsevier in Addictive Behaviors
- Vol. 178, 108659
Drug positivity, co-detection patterns, and demographic predictors in patients seeking substance use disorder treatment, United States, 2023
- 11 March 2026
- Published by Elsevier in Addictive Behaviors
- Vol. 178, 108659
Drug positivity, co-detection patterns, and demographic predictors in patients seeking substance use disorder treatment, United States, 2023
- 1 November 2024
- Published by American Public Health Association in American Journal of Public Health
- Vol. 114 (S8) , S624-S627
Current Cannabis Use in the United States: Implications for Public Health Research
- 1 November 2024
- Published by American Public Health Association in American Journal of Public Health
- Vol. 114 (S8) , S624-S627
Current Cannabis Use in the United States: Implications for Public Health Research
- Open Access
- 10 June 2022
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 5 (6) , e2216475
Patterns in Nonopioid Pain Medication Prescribing After the Release of the 2016 Guideline for Prescribing Opioids for Chronic Pain
The drug overdose epidemic has greatly affected the US in the past 2 decades both in terms of mortality (with 92 000 deaths in 2020 and high provisional estimates in 2021)1,2 and associated harms, such as opioid use disorder.3 Although opioid overdose mortality dynamics have shifted during this period,4-6 prescription opioids have remained a critical factor in opioid-related morbidity and mortality.7-9 Recognizing the need for evidence-based guidelines for safe opioid prescribing, the Centers for Disease Control and Prevention (CDC) released the Guideline for Prescribing Opioids for Chronic Pain10 in March 2016.
- 10 June 2022
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 5 (6) , e2216475
Open AccessPatterns in Nonopioid Pain Medication Prescribing After the Release of the 2016 Guideline for Prescribing Opioids for Chronic Pain
The drug overdose epidemic has greatly affected the US in the past 2 decades both in terms of mortality (with 92 000 deaths in 2020 and high provisional estimates in 2021)1,2 and associated harms, such as opioid use disorder.3 Although opioid overdose mortality dynamics have shifted during this period,4-6 prescription opioids have remained a critical factor in opioid-related morbidity and mortality.7-9 Recognizing the need for evidence-based guidelines for safe opioid prescribing, the Centers for Disease Control and Prevention (CDC) released the Guideline for Prescribing Opioids for Chronic Pain10 in March 2016.
- 23 March 2021
- Published by American Medical Association (AMA) in JAMA
- Vol. 325 (12) , 1151-1152
Continued Increases in Overdose Deaths Related to Synthetic Opioids
This Viewpoint summarizes a 2021 MMWR report documenting a concerning rise in illicit and synthetic opioid overdose deaths in the US between 2013 and 2019 and p
- 23 March 2021
- Published by American Medical Association (AMA) in JAMA
- Vol. 325 (12) , 1151-1152
Continued Increases in Overdose Deaths Related to Synthetic Opioids
This Viewpoint summarizes a 2021 MMWR report documenting a concerning rise in illicit and synthetic opioid overdose deaths in the US between 2013 and 2019 and p
- 1 January 2018
- Published by Elsevier
- Vol. 158, 63-74
Epidemiology of sports concussion in the United States
- 1 January 2018
- Published by Elsevier
- Vol. 158, 63-74
Epidemiology of sports concussion in the United States
- Open Access
- 30 August 2017
- Published by Springer Nature in Population Health Metrics
- Vol. 15 (1) , 1-10
Increases in United States life expectancy through reductions in injury-related death
During the previous century the average lifespan in the United States (US) increased by over 30 years, with much of this increase attributed to public health initiatives. This report examines further gains that might be achieved through reduced occurrence of injury-related death. US life tables and injury death rate data were used to estimate potential increases in life expectancy assuming various reductions in the rate of fatal injuries. Corresponding numbers of deaths potentially averted annually were also estimated; unit (per death) medical and lifetime work loss costs were employed to estimate total costs potentially averted annually. Through elimination of injury as a cause of death, average US life expectancy at birth could be increased by approximately 1.5 years, with notable variations by sex, ethnicity, and race. More conservatively, average life expectancy at birth could be increased by 0.41 years assuming that the national injury death rate could be brought into line with the lowest state-specific rate. Under this more conservative but plausible assumption, an estimated 48,400 injury deaths and $61 billion in medical and work loss costs would be averted annually. Increases in life expectancy of the magnitude considered in this report are arguably attainable based on long-term historical reductions in the US injury death rate, as well as significant continuing reductions seen in other developed countries. Contemporary evidence-based interventions can play an important role in reducing injury-related deaths, such as those due to drug overdoses and older adult falls, as well as suicides.
- 30 August 2017
- Published by Springer Nature in Population Health Metrics
- Vol. 15 (1) , 1-10
Open AccessIncreases in United States life expectancy through reductions in injury-related death
During the previous century the average lifespan in the United States (US) increased by over 30 years, with much of this increase attributed to public health initiatives. This report examines further gains that might be achieved through reduced occurrence of injury-related death. US life tables and injury death rate data were used to estimate potential increases in life expectancy assuming various reductions in the rate of fatal injuries. Corresponding numbers of deaths potentially averted annually were also estimated; unit (per death) medical and lifetime work loss costs were employed to estimate total costs potentially averted annually. Through elimination of injury as a cause of death, average US life expectancy at birth could be increased by approximately 1.5 years, with notable variations by sex, ethnicity, and race. More conservatively, average life expectancy at birth could be increased by 0.41 years assuming that the national injury death rate could be brought into line with the lowest state-specific rate. Under this more conservative but plausible assumption, an estimated 48,400 injury deaths and $61 billion in medical and work loss costs would be averted annually. Increases in life expectancy of the magnitude considered in this report are arguably attainable based on long-term historical reductions in the US injury death rate, as well as significant continuing reductions seen in other developed countries. Contemporary evidence-based interventions can play an important role in reducing injury-related deaths, such as those due to drug overdoses and older adult falls, as well as suicides.
- 26 October 2013
- Published by Springer Nature
- p. 99-100
The Burden of Drowning: Issues in Selected Countries – The United States
- 26 October 2013
- Published by Springer Nature
- p. 99-100
The Burden of Drowning: Issues in Selected Countries – The United States
- 1 January 2010
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 38 (1) , S218-S221
It Wouldn't Hurt to Create a Safer Military
- 1 January 2010
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 38 (1) , S218-S221
It Wouldn't Hurt to Create a Safer Military